Home / Recalls / Attix Pharmaceuticals Inc / D-1047-2016

D-1047-2016 Class III Terminated

Recalled by Attix Pharmaceuticals Inc — Toronto, N/A

Recall Details

Product Type: Drugs
Report Date: June 29, 2016
Initiation Date: May 18, 2016
Termination Date: July 26, 2016
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: N/A

Product Description

Mycophenolate Mofetil, Bulk Powder, Quantity 1000 g, For prescription compounding use and medical manufacturing or processing only, Attix Pharmaceuticals, Toronto, Canada

Reason for Recall

cGMP deviation; manufacturer is Not Registered with the Food and Drug Administration

Distribution Pattern

Code Information

Lot Number: A3160A, Manufacturer batch number: 151201, Expiry November 2017

Other recalls by Attix Pharmaceuticals Inc

D-946-2015 Class II — Uridine-5'Triphosphate Trisodium Salt active pharmaceutical ingredient packaged (November 14, 2014)
D-705-2015 Class II — Histamine Diphosphate active pharmaceutical ingredient packaged in varying grams (November 14, 2014)
D-579-2015 Class II — Chloroquine Phosphate active pharmaceutical ingredient packaged in varying grams (November 14, 2014)
D-851-2015 Class II — Potassium Phosphate Monobasic pharmaceutical ingredient packaged in varying gram (November 14, 2014)
D-554-2015 Class II — Cabergoline active pharmaceutical ingredient packaged in varying grams or kg in (November 14, 2014)
D-807-2015 Class II — Montelukast Sodium active pharmaceutical ingredient packaged in varying grams or (November 14, 2014)
D-939-2015 Class II — Tranilast active pharmaceutical ingredient packaged in varying grams or kg in ba (November 14, 2014)
D-701-2015 Class II — Guanabenz Acetate active pharmaceutical ingredient packaged in varying grams or (November 14, 2014)
D-641-2015 Class II — Doxycycline HCI active pharmaceutical ingredient packaged in varying grams or kg (November 14, 2014)
D-661-2015 Class II — Ethinyl Estradiol active pharmaceutical ingredient packaged in varying grams or (November 14, 2014)